Cleared Traditional

K834033 - KINETIC ALKALINE PHOSPHATASE

K834033 is the FDA 510(k) clearance for KINETIC ALKALINE PHOSPHATASE by American Monitor Corp.. It is a Class 2 Chemistry device (product code CJE) cleared through the Traditional 510(k) pathway after a 68-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
68d
Days
Class 2
Risk

K834033 is an FDA 510(k) clearance for the KINETIC ALKALINE PHOSPHATASE. Classified as Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes (product code CJE), Class II - Special Controls.

Submitted by American Monitor Corp. (Mchenry, US). The FDA issued a Cleared decision on January 30, 1984 after a review of 68 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1050 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Monitor Corp. devices

Submission Details

510(k) Number K834033 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 23, 1983
Decision Date January 30, 1984
Days to Decision 68 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 88d · This submission: 68d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes

All 84
Devices cleared under the same product code (CJE) and FDA review panel - the closest regulatory comparables to K834033.
SYSTEMATE ALKALINE PHOSPHATASE-67203
K843270 · Em Diagnostic Systems, Inc. · Sep 1984
ALKALINE PHOSPHATASE ASSAY KIT
K842243 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SIGMA PROCED. 245 ALKALINE PHOSPHATASE
K841918 · Sigma Diagnostics, Inc. · Jun 1984
RAICHEM ALKALINE PHOSPHATASE REAGENT
K832463 · Reagents Applications, Inc. · Sep 1983
PARAMAX ALKALINE PHOSPHATASE REAGENT-
K831480 · American Dade · Jun 1983
DATA-ZYME ALKALINE PHOSPHATASE PROCED
K831360 · Data Medical Associates, Inc. · Jun 1983